Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 19/20 | 0.78 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22230104 | 0.93 | TOP1 (0.80) | TOP1SLC2A1 | |
| SCHEMBL22230084 | 0.93 | TOP1 (0.87) | TOP1 | |
| SCHEMBL22230172 | 0.91 | TOP1 (0.75) | TOP1SLC2A1 | |
| SCHEMBL23255589 | 0.90 | TOP1 (0.73) | TOP1SLC2A1 | |
| SCHEMBL21592225 | 0.89 | TOP1 (0.72) | TOP1SLC2A1 | |
| SCHEMBL23255710 | 0.89 | TOP1 (0.72) | TOP1SLC2A1 | |
| SCHEMBL21591948 | 0.89 | TOP1 (0.72) | TOP1SLC2A1 | |
| SCHEMBL21564110 | 0.89 | TOP1 (0.87) | TOP1SLC2A1 | |
| SCHEMBL22230099 | 0.89 | TOP1 (0.73) | TOP1SLC2A1 | |
| SCHEMBL24642747 | 0.89 | TOP1 (0.86) | TOP1SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112770755-A | Compositions, syntheses, preparations and uses of analogs derived from position 7 and 9 of platform drug FL118 for treating human diseases | 坎格特生物技术制药有限责任公司 | 2021-05-07 | — | — | CN | disclosed |
| US-20200231596-A1 | MATTER OF COMPOSITION, SYNTHESIS, FORMULATION AND APPLICATION OF FL118 PLATFORM POSITIONS 7 AND 9-DERIVED ANALOGUES FOR TREATMENT OF HUMAN DISEASE | CANGET BIOTEKPHARMA | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200231596-A1 | MATTER OF COMPOSITION, SYNTHESIS, FORMULATION AND APPLICATION OF FL118 PLATFORM POSITIONS 7 AND 9-DERIVED ANALOGUES FOR TREATMENT OF HUMAN DISEASE | TP53, BRCA1, MET | TOP1 2368/4885SLC2A1 4162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.